Please log in to your account or sign up in order to add this asset to your watchlist. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn about financial terms, types of investments, trading strategies and more. Learn everything you need to know about successful options trading with this three-part video course. Identify stocks that meet your criteria using seven unique stock screeners. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The latest closing stock price for Bristol Myers Squibb as of February 10, 2021 is 60.00.. Looking for new stock ideas? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Your current $100 investment may be up to $111.15 in 2026. Receive a free world-class investing education from MarketBeat. - Try Now Risk-Free - Money-back guarantee! See what's happening in the market right now with MarketBeat's real-time news feed. Learn more. The all-time high Bristol Myers Squibb stock closing price was 77.94 on October 28, 1999.; The Bristol Myers Squibb 52-week high stock price is 67.16, which is 11.9% above the current share price. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Stock split history for Bristol Myers Squibb since 1972. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits. Start Your Risk-Free Trial Subscription Here, Sociedad Quimica Stock is a Real Deal EV Lithium Play, Global shares extend gains on global optimism, vaccine hopes, Luxury car brand Jaguar to go all-electric by 2025, Tokyo surges to 30-year high as world shares rally, World stocks rally, bringing Japanese market to 30-year high, Biden faces questions about commitment to minimum wage hike, Revisiting Limelight Networks Stock as a Streaming Winner, Sketchers U.S.A. Stock is a Pullback Opportunity Here, 3 Stocks Under $20 Set for Big 2021 Gains, 3 Dating App Stocks for Investors to Love, 3 Consumer Discretionary Stocks Ready to Run, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, Receive Analysts' Upgrades and Downgrades Daily. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The high price target for BMY is $88.00 and the low price target for BMY is $65.00. On November 30, 2020 "Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell" gave "" rating for BMY. Want to see which stocks are moving? The lighter blue line represents the stock's consensus price target. With a 5-year investment, the revenue is expected to be around +11.15%. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. Learn about financial terms, types of investments, trading strategies and more. Find real-time BMY - Bristol-Myers Squibb Co stock quotes, company profile, news and forecasts from CNN Business. Based on our forecasts, a long-term increase is expected, the "BMY" stock price prognosis for 2026-02-06 is 66.663 USD. You can opt out at any time. BMY updated stock price target summary. Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. You can opt out at any time. All rights reserved. A number of other hedge funds also recently made changes to […] Export data to Excel for your own analysis. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Bristol-Myers Squibb Co (NYSE:BMY) posted its earnings results on Thursday, April, 25th. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. To see all exchange delays and terms of use please see disclaimer. Aaron Wealth Advisors purchased a new position in Bristol-Myers Squibb (NYSE:BMY) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 18,666 shares of the biopharmaceutical company’s stock, valued at approximately $1,157,000. View which stocks are hot on social media with MarketBeat's trending stocks report. Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. The biopharmaceutical company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.09 by $0.01. The dark blue line represents the company's actual price. Based on analysts offering 12 month price targets for BMY in the last 3 months. Get Bristol-Myers Squibb alerts: BMY stock traded down $0.09 during mid-day trading … Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BMY stock is a recommendation set at 1.90. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. Get short term trading ideas from the MarketBeat Idea Engine. Their average twelve-month price target is $74.27, predicting that the stock has a possible upside of 23.78%. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). According to . Zacks Investment Research - 1 week ago What's in the Cards for Bristol-Myers' (BMY) Q4 Earnings? And so with BMY crossing above that average target price of $64.00/share, investors in BMY have been given a good signal to spend fresh time … Here is what top equities market gurus are saying about Bristol-Myers Squibb Company [BMY]: Based on careful and fact … They issued a “hold” rating and a $65.00 price target on the stock. Looking for new stock ideas? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Give thumbs up if you really like the trade idea. Start Your Risk-Free Trial Subscription Here, Sociedad Quimica Stock is a Real Deal EV Lithium Play, Global shares extend gains on global optimism, vaccine hopes, Luxury car brand Jaguar to go all-electric by 2025, Tokyo surges to 30-year high as world shares rally, World stocks rally, bringing Japanese market to 30-year high, Biden faces questions about commitment to minimum wage hike, Revisiting Limelight Networks Stock as a Streaming Winner, Sketchers U.S.A. Stock is a Pullback Opportunity Here, 3 Stocks Under $20 Set for Big 2021 Gains, 3 Dating App Stocks for Investors to Love, 3 Consumer Discretionary Stocks Ready to Run, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Receive Analysts' Upgrades and Downgrades Daily. The average price target is $37.00 with a high forecast of $38.00 and a low forecast of $36.00. Average Price Target. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. 11 Wall Street analysts that have issued a 1 year BMY price target, the average BMY price target is $73.09, with the highest BMY stock price forecast at $80.00 and the lowest BMY stock price forecast at $66.00. Stocks turning up in the middle of a horizontal trend … Do Not Sell My Information. See what's happening in the market right now with MarketBeat's real-time news feed. About the Bristol Myers Squibb Co. stock forecast. As of 2021 February 12, Friday current price of BMY stock is 59.975$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Bristol Myers Squibb Co. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. BMY-R price target in 14 days: 3.509 USD* upside and 2.861 USD* downside. The average price target represents a 54.55% increase from the … Receive a free world-class investing education from MarketBeat. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Please see the "Historical Prices" tab for adjusted price values. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). The biopharmaceutical company earned $5.92 billion during the quarter, compared to analysts' expectations of $5.72 billion. The dark blue line represents the company's actual price. Get short term trading ideas from the MarketBeat Idea Engine. View today's stock price, news and analysis for Bristol Myers Squibb Co. (BMY). MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. EKSO Ekso Bionics $13.04 / +2.59 (+24.78%) 06/26/20 H.C. Wainwright Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright. The price target was set to $73.00 → $77.00. View which stocks are hot on social media with MarketBeat's trending stocks report. © American Consumer News, LLC dba MarketBeat® 2010-2021. Beta is a measure of volatility relative to the stock market at large; for BMY, its beta is lower than 93.6% of stocks in the large-sized revenue class. The high price target for BMY is $88.00 and the low price target for BMY is $65.00. BRISTOL-MYERS SQUIBB COMPANY (NYSE:BMY) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BRISTOL-MYERS SQUIBB COMPANY | Nyse: BMY | Nyse 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The average price target is $77.83 with a … Get Our PREMIUM Forecast Now, from ONLY $7.49! As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. BMY will have the option to obtain an exclusive worldwide license to develop and commercialize ETBs directed to each selected target. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold.". Want to see which stocks are moving? Learn more. Fundamental company data provided by Zacks Investment Research. Bristol Myers Squibb Co. analyst estimates, including BMY earnings per share estimates and analyst recommendations. During the sam… BMY: Get the latest Bristol-Myers Squibb stock price and detailed information including BMY news, historical charts and realtime prices. Buy in pull back with stop level below 59.90 for target above 67. Get daily stock ideas top-performing Wall Street analysts. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. Identify stocks that meet your criteria using seven unique stock screeners. To see all exchange delays and terms of use please see disclaimer. BMY - It is in 3rd of C of Y wave up. View our full suite of financial calendars and market data tables, all for free. If compared to the average trading volume of 10.35M shares, BMY reached a trading volume of 10236162 in the most recent trading day, which is why market watchdogs consider the stock to be active. Given the current horizontal trend, you can expect Bristol-Myers Squibb Company stock with a 90% probability to be traded between $59.99 and $67.05 at the end of this 3-month period. Learn everything you need to know about successful options trading with this three-part video course. 15 Wall Street analysts have issued ratings and price targets for Bristol-Myers Squibb in the last 12 months. Export data to Excel for your own analysis. Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BMY shares is $74.94 per share. Take-Two price target raised to $204 from $199 at Credit Suisse 07:25 Today Barclays Take-Two price target raised to $220 from $210 at Barclays. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Please log in to your account or sign up in order to add this asset to your watchlist. Get daily stock ideas top-performing Wall Street analysts. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. The lighter blue line represents the stock's consensus price target. 10 ETFs With Most Upside To Analyst Targets Fundamental company data provided by Zacks Investment Research. The chart below shows how a company's share price and consensus price target have changed over time. BMY stock price has been found in the range of $60.33 to $61.56. © American Consumer News, LLC dba MarketBeat® 2010-2021. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. (Highest and lowest possible predicted price in a 14 day period) Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . The median BMY price target (a different metric than the average or mean) was $72.0 as of 2021-02-08, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $66.0, with a standard deviation of $4.742. Do Not Sell My Information. All rights reserved. Learn more. The company's revenue for the quarter was up 14.0% on a year-over-year basis. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. There are currently 4 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy.". MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Prices shown are actual historical values and are not adjusted for either splits or dividends. Learn more. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Bristol-Myers Squibb had a return on equity of 48.72% and a net margin of 22.23%. Average target price: 75,17 $ Last Close Price: 60,92 $ Spread / Highest target: 41,2%: Spread / Average Target: 23,4%: Spread / Lowest Target: 8,34% The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold." MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.28, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.72. Bloomsbury Publishing plc (BMY.L) (LON:BMY) Consensus Price Target History Average Share Price and Price Target by Month MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. (29.74% Upside) Based on 6 analysts offering 12 month price targets for Bristol Myers in the last 3 months. Bristol Myers Squibb Co's variance in analysts' estimates is lower than 77.79% of stocks in the large market cap category. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The shares of Bristol-Myers Squibb Co (NYSE:BMY) are up 1.6% at $62.39 at last check, just ahead of the pharmaceutical name's fourth-quarter earnings, due out before the open on Thursday, Feb. 4. View our full suite of financial calendars and market data tables, all for free. Analyst Price Target on BMY. 15 Wall Street analysts have set twelve-month price targets for Bristol-Myers Squibb in the … View real-time stock prices and stock quotes for a full financial overview. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. This rating represents a strong Buy recommendation, on the scale from 1 … $77.83. The chart below shows how a company's share price and consensus price target have changed over time. Get the latest Zacks research report on BMY — FREE. Their average twelve-month price target is $74.27, predicting that the stock has a possible upside of 23.80%. The average analyst price target of BMY is greater than 88.24% of Pharmaceutical Products stocks. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. There are currently 4 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy." Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy).